Search
Osimertinib (AZD9291) is used to treat non-small cell lung cancer. Osimertinib (AZD9291) is a oral, third generation, small-molecule epidermal growth factor receptor (EGFR) inhibitor and antineoplastic agent. In addition, it is a Cytochrome P450 3A inhibitor, and Cytochrome P450 3A4 Inducer, and Cytochrome P450 1A2 Inducer, and Breast Cancer Resistance Protein Inhibitor. It is used for the treatment of advanced non-small cell lung cancer (NSCLC) where mutant EGFR form (such as T790M) is often presented. Through suppressing the EGFR-mediated signalling, it cause cell death and inhibit tumour growth in related cancer cells.
| Items | Specifications | Results |
| Appearance | White crystalline powder | Conforms |
| Assay | ≥99% | 99.69% |
| Product parameters | |
| Cas number: | 1421373-65-0 |
| Appearance: | White crystalline powder |
| Purity: | 99%min |
| Package details: | 100g/bottle; 1kg/foil bag |
| Brand: | Fortunachem |

Used as a antineoplastic Agent.

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية